Overview
How do countries across the globe collaborate effectively to deliver innovative pharmaceutical products, medical devices, and regenerative medical products to patients, in the fastest, most efficient way possible?
With healthcare product development becoming increasingly global, the time has come to deepen the discussion on how to leverage the individual strengths of countries, promote better collaboration, and strengthen global partnerships, to build the ideal system for creating medicines, medical devices, and regenerative medical products.
Further, innovative technologies such as artificial intelligence, big data/genomics, and cell/gene therapies are poised to transform healthcare product development across the globe – join us as at the DIA Japan Annual Meeting 2018, to discuss these topics and the future of healthcare.
We look forward to welcoming you at Tokyo Big Sight from November 11-13, 2018 for stimulating discussions around promoting better collaboration to drive global health and innovation in this era of medical and scientific transformation.
We hope to see you there!
Program Committee
-
Takuko Sawada • Director of the Board, Sr Executive Officer, Sr VP, Corporate Strategy Division
Shionogi & Co., Ltd., Japan -
Kazuhiro Kanmuri, PhD • Director/CEO
CTD Inc./inter-Professional Inc., Japan -
Taro Amagasaki, PhD • Department Head, Integrated Biostatistics Japan Department
Novartis Pharma K.K., Japan -
Noriko Fujiwara, MS, RN • Research Nurse, Project Researcher, Department of Palliative Medicine
IMSUT Hospital, The Institute of Medical Science, The University of Tokyo, Japan -
Yoshikata Furuya, MSc • Director, Vaccine Policy, Health Policy
MSD K.K., Japan -
Shinzo Hiroi, MPH, RPh, PMP • Head of Global Medical Affairs, Global Medical Affairs
Shionogi & Co., Ltd., Japan -
Kazuo Ichikawa, PhD, PMP • Senior Staff Adviser, Group II, Global Project Management Department, R&D Div.
Daiichi Sankyo Co., Ltd., Japan -
Katsuhiko Ichimaru • Director, Information Disclosure Division, Office of Review Management
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Akiko Ikeda, RPh • Senior Manager, Policy Intelligence Dept., Integrated Market Access Division
Janssen Pharmaceutical K.K., Japan -
Toshiko Ishibashi, PhD, RN • Associate Clinical Operations Manager, Japan Site Management & Monitoring
AbbVie GK, Japan -
Kazuhiko Ishida, MSc, RPh • Associate Director, Pharmacovigilance
Astellas Pharma Inc., Japan -
Miyuki Kaneko • Manager, Japan Regulatory Lead
Pfizer Japan Inc., Japan -
Yoko Kazami, PMP • Manager
Nobelpharma Co., Ltd., Japan -
Noriatsu Kono • Senior Director, Global Project Management
Japan Agency for Medical Research and Development (AMED), Japan -
Yukihiro Matsuda, MSc • Research Scientist, Trial Mgmt., Clinical Development Operations & Innovatiion
Eli Lilly Japan K.K., Japan -
Yasutsugu Nakano • Senior Director, Head of Regulatory Affairs 3, Global Regulatory Affairs Dept.
Shionogi & Co., Ltd., Japan -
Motohide Nishi, MBA • Vice President, Asia Pacific Technology
Medidata Solutions K.K., Japan -
Minori Niso • Manager, Corporate Marketing
PAREXEL International Inc., Japan -
Atsushi Noguchi, MS • Reviewer, Office of New Drug V
Pharmaceuticals and Medical Devices Agency, Japan -
Kimiya Okazaki, PharmD, PhD • Associate Department Manager, Regulatory Intelligence, Regulatory Affairs
GlaxoSmithKline K.K., Japan -
Mikiko Shitara • Team Leader, Labeling Dept., RA, Development & Medical Affairs Div.
GlaxoSmithKline K.K., Japan -
Kuniko Shoji • Director and Corporate Advisor
Terumo Corporation, Japan -
Keiko Tsumori • Associate Director, Medical Writing, Regulatory Affairs Area, Japan Development
MSD K.K., Japan -
Tadashi Urashima, PhD • Manager (Strategy Deployment and Digital Practices), MA Excellence Dept.
GlaxoSmithKline K.K., Japan -
Koichiro Yuji, MD, PhD, FACP • Project Associate Professor, Project Div. of Int'l Advanced Medical Research
Institute of Medical Science, The University of Tokyo, Japan -
Junichi Nishino, MSc, RPh • Head, RA Functions Department, Regulatory Office Japan
Novartis Pharma K.K., Japan -
Junko Sato, PhD • Office Director, Office of International Cooperation
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Atsushi Tsukamoto, PhD, MSc • Vice President, New Drug Regulatory Affairs
Daiichi Sankyo Co., Ltd., Japan
